TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2026
Back to search
Official data from USPTO
X-PATH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
X-PATH
ST13
US500000088333627Class
1, 5, 10, 42, 44
Filing
88333627
Registration
6880311
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
03/05/2026
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
03/11/2019
Registration date
10/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
03/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-07-00
First use in commerce
2022-07-00
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ, US
Examiner
MAIHOS, JESSIE ANDREA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
E. C. (pessoa física)
Representatives
Xiongying Tu Schwabe, Williamson & Wyatt, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposesin vitro and in vivo scientific usethe testing of bodily fluidsthe detecting and analyzing of cellsproteinssmall moleculesnucleotides; Biological and chemical test kits comprised of biologicalchemicaldiagnostic reagents for the detection and identification of nucleic acidsDNA and RNA in a samplefor laboratory and research use
Class 5
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cellsproteinssmall moleculesnucleotidesnucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluidscellsproteinssmall moleculesnucleotidesnucleic acids for use in disease detectioncancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases
Class 10
Medical diagnostic apparatus for testing cellstissuebiomoleculesproteinssmall moleculesnucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic usemedical apparatus for diagnostic testing of health conditionsdiseasesabnormalitiesin the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesendocrine diseasesother tissue-based diagnostic testingcytologycell based testing; Medical apparatusdevicesinstruments for wellness testinghealth condition testinghealthcare testingpoint-of-care diagnostic devicesat-home diagnostic devicesportable health monitoring devices that detect health conditions and diseases in the nature of cancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseases and genetic diseases; Medical apparatusdevicesinstruments for the detection and identification of nucleic acidsDNA and RNA in a samplein the nature of apparatus for DNA and RNA testing for medical purposes
Class 42
Scientific laboratory servicesdetection and identification of cellsproteinssmall moleculesnucleotides in a sample for scientificresearchtechnological purposes; Medical laboratory servicesproviding medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnologyDNARNAsmall moleculesproteinsnucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trialsassays and assay developmentdiagnosticscancerRNADNAsmall moleculesproteinsnucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncologyhematologyinfectious diseases
Class 44
Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare servicesthe diagnosis of diseasescancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic servicesmedical testing for diagnostic purposes; Wellness servicesproviding wellness information in the fields of health and wellness; Medical services for the detection and identification of cellsproteinssmall moleculesnucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
50 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/14/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/13/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/09/2022
IUAF
USE AMENDMENT FILED
08/04/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/05/2022
EX4G
SOU EXTENSION 4 GRANTED
02/03/2022
EXT4
SOU EXTENSION 4 FILED
02/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/10/2021
EX3G
SOU EXTENSION 3 GRANTED
08/09/2021
EXT3
SOU EXTENSION 3 FILED
08/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/27/2021
EX2G
SOU EXTENSION 2 GRANTED
01/25/2021
EXT2
SOU EXTENSION 2 FILED
01/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/25/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/13/2020
EX1G
SOU EXTENSION 1 GRANTED
11/12/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/09/2020
NREV
NOTICE OF REVIVAL - E-MAILED
09/29/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
09/29/2020
PETG
PETITION TO REVIVE-GRANTED
09/29/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
09/29/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
09/08/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
09/07/2020
EXT1
SOU EXTENSION 1 FILED
08/04/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
ALIE
ASSIGNED TO LIE
11/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/04/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/04/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/04/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2019
GNRT
NON-FINAL ACTION E-MAILED
05/08/2019
CNRT
NON-FINAL ACTION WRITTEN
05/08/2019
DOCK
ASSIGNED TO EXAMINER
05/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2019
NWAP
NEW APPLICATION ENTERED
03/14/2019
Continuous trademark protection
Get notified about every new filing that threatens X-PATH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.